Publication | Closed Access

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study

Antifungal AgentLiposomal AmphotericinAntifungal AgentsFungal InfectionsPathologyPlacebo-controlled StudyClinical MycologyDermatologyMedicineFungal PathogenDrug Resistance